Axa PPP removes cancer cover limits


Axa PPP has removed all cost and time limits for licensed cancer drug treatment for patients on its standard individual and SME plans.

It comes as part of the insurer's new commitment to cancer and heart disease coverage including improved treatment terms for policyholders. The provider is also waiving any monetary limits that may apply to out-patient tests and consultations for cancer patients and will offer experimental drugs when pre-agreed as part of an ethical trial. Injectable hormone treatment and bisphosphonate treatment used to manage cancer are fully covered during active treatment, while requests for experimental surgery will be considered. Heart surgery patients will also benefit from no time limits to...

To continue reading this article...

Join Professional Adviser for free

  • Unlimited access to real-time news, industry insights and market intelligence
  • Stay ahead of the curve with spotlights on emerging trends and technologies
  • Receive breaking news stories straight to your inbox in the daily newsletters
  • Make smart business decisions with the latest developments in regulation, investing retirement and protection
  • Members-only access to the editor’s weekly Friday commentary
  • Be the first to hear about our events and awards programmes



Already a Professional Adviser member?


More on Individual

Bupa launches new patient helpline

Bupa has launched Bupa Anytime HealthLine, a helpline providing 24 hour, unlimited medical advice and information from a team of GPs and nurses.

clock 24 January 2012 •

Freedom Healthnet widens age limit

Freedom Healthnet has upped the age limit for clients wishing to purchase its private medical insurance (PMI) plan.

clock 16 January 2012 •

Brokers approve cancer cover moves

Medical insurance brokers have applauded moves by private medical insurance (PMI) providers to remove the limits on cancer coverage for many standard polices.

clock 10 January 2012 •